splenic manifestation of prolymphocytic leukemia

Description

Splenic Manifestation of Prolymphocytic Leukemia

The splenic manifestation of prolymphocytic leukemia refers to the infiltration and expansion of the white and red pulp of the spleen by prolymphocytic leukemia cells [6]. This condition is characterized by the accumulation of malignant B-lymphocytes in the spleen, leading to its enlargement (splenomegaly) [2].

Key Features:

  • Infiltration and expansion of the white and red pulp of the spleen by prolymphocytic leukemia cells
  • Splenomegaly (enlarged spleen)
  • High WBC count due to the proliferation of malignant B-lymphocytes
  • Absent or minimal lymphadenopathy (swelling of lymph nodes)

Clinical Presentation:

Patients with splenic manifestation of prolymphocytic leukemia often present with advanced disease, characterized by: * B-symptoms (fevers, night sweats, weight loss) * Massive splenomegaly * Absent or minimal lymphadenopathy * High WBC count

Diagnosis:

The diagnosis of splenic manifestation of prolymphocytic leukemia is typically made based on a combination of clinical presentation, laboratory findings (e.g., high WBC count), and histopathological examination of the spleen tissue [8].

References: [2] - Prolymphocytic leukemia is a rare lymphoproliferative disorder characterized by splenomegaly and high WBC between 50 000 and 200 000 cells/μl at diagnosis with circulating lymphocytes of predominant B-cell phenotype. [6] - Splenic Manifestation of Prolymphocytic Leukemia. Definition: Infiltration and expansion of the white and red pulp of the spleen by prolymphocytic leukemia. [8] - Patients often present with advanced disease: B-symptoms, massive splenomegaly, absent or minimal lymphadenopathy, and high WBC count.

Signs and Symptoms

Common signs and symptoms associated with splenic manifestations of prolymphocytic leukemia include:

  • Enlarged spleen (splenomegaly) [1]
  • High lymphocyte count [2]
  • B-symptoms, such as fevers, night sweats, and weight loss [2]
  • Anaemia due to lack of red blood cells [4]
  • More frequent, severe, and prolonged infections due to lack of normal white blood cells [4]

Additional symptoms may include:

  • Pain in the upper left portion of the abdomen caused by an enlarged spleen [5]
  • Fatigue [5]
  • Fever [11]
  • Frequent or severe infections [11]
  • Losing weight without trying [11]

It's worth noting that splenic manifestations of prolymphocytic leukemia can vary from person to person, and not everyone will experience all of these symptoms.

References: [1] - Context result 1 [2] - Context result 2 [4] - Context result 4 [5] - Context result 15

Additional Symptoms

  • Losing weight without trying
  • Enlarged spleen (splenomegaly)
  • High lymphocyte count
  • B-symptoms, such as fevers, night sweats, and weight loss
  • Anaemia due to lack of red blood cells
  • More frequent, severe, and prolonged infections due to lack of normal white blood cells
  • Pain in the upper left portion of the abdomen caused by an enlarged spleen
  • Frequent or severe infections
  • fever
  • fatigue

Diagnostic Tests

Treatment

Based on the provided context, here are some potential treatment options for the splenic manifestations of prolymphocytic leukemia:

  • Splenectomy: According to search result 7 [number], splenectomy should be considered in patients with prolymphocytic leukemia, especially when there is significant splenomegaly.
  • Splenic irradiation: Search result 7 also recommends splenic irradiation as an initial treatment option for prolymphocytic leukemia. This can help reduce spleen size and alleviate symptoms.
  • Chlorambucil/prednisone: As mentioned in search result 7, chlorambucil/prednisone is another treatment option that can be used to manage the splenic manifestations of prolymphocytic leukemia.

It's worth noting that more recent studies have shown that monoclonal antibodies, such as alemtuzumab, may be more effective in treating prolymphocytic leukemia. However, these treatments are typically reserved for patients who do not respond to initial therapies or have relapsed disease.

In terms of specific treatment regimens, search result 9 mentions the use of chemo-immunotherapy combinations used to treat chronic lymphocytic leukemia (CLL), which may also be effective in treating prolymphocytic leukemia. However, further research is needed to confirm this.

References:

  • Search result 7: "Recommendations are made to use chlorambucil/prednisone and splenic irradiation as initial treatments for prolymphocytic leukemia."
  • Search result 9: "Common regimens include: FCR [fludarabine, cyclophosphamide, and rituximab] used to treat CLL."

Recommended Medications

  • Splenectomy
  • Splenic irradiation
  • prednisone

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of splenic manifestations of prolymphocytic leukemia (PLL) involves a range of conditions that can present with similar symptoms, such as splenomegaly and lymphocytosis. Based on the search results, here are some key points to consider:

  • Mantle cell lymphoma: This is a type of non-Hodgkin lymphoma that can present with splenomegaly and lymphocytosis, similar to PLL.
  • Chronic lymphocytic leukemia (CLL) with prolymphocytes: CLL is a common type of leukemia in adults, and some cases may present with prolymphocytes, which can be confused with PLL.
  • Hairy cell leukemia: This is a rare type of leukemia that can present with splenomegaly and lymphocytosis, similar to PLL.
  • Splenic marginal zone B-cell lymphoma (SMZL): SMZL is a type of non-Hodgkin lymphoma that can present with splenomegaly and lymphocytosis, similar to PLL.

According to search result [6], the differential diagnosis of B-PLL includes atypical CLL (CLL/PLL), HCL variant, MCL, and SMZL. Search result [8] also mentions that the differential diagnosis of B-PLL is with CLL/PL, leukemic MCL, HCL-V, SMZL, and T-PLL.

In terms of specific features, search result [10] notes that B-PLL typically presents with giant spleen without obvious enlargement of lymph nodes, while T-PLL mostly has enlargement of liver, spleen, and lymph nodes. Search result [11] also mentions that the primary manifestations of prolymphocytic leukemia are in the peripheral blood, bone marrow, and spleen.

Overall, the differential diagnosis of splenic manifestations of PLL is complex and requires careful consideration of various conditions that can present with similar symptoms.

References:

  • Search result [6]
  • Search result [8]
  • Search result [10]
  • Search result [11]

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:4334
core#notation
DOID:4334
oboInOwl#hasDbXref
UMLS_CUI:C1336066
rdf-schema#label
splenic manifestation of prolymphocytic leukemia
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_710
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_10838

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.